Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers-Reference-Cited by-同舟云学术

Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers

Published:1991-10 Issue:10 Volume:59 Page:3841-3845
ISSN:0019-9567
Container-title:Infection and Immunity
language:en
Short-container-title:Infect Immun

Author:

Bao J X¹,Clements J D¹

Affiliation:

1. Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana 70112.

Abstract

Prior immunologic experience with homologous and heterologous serotype Salmonella strains potentiated the subsequent antibody response when the same strains were used as vaccine carriers of foreign antigens. This potentiation was positively correlated with the appearance of antibody directed against the lipopolysaccharide of the carrier strain. Both serum and mucosal antibody responses against the foreign antigen increased over time. Antibody responses in sera of animals primed with either the homologous or heterologous serotype strain were not statistically significantly different, while animals primed with the homologous serotype strain developed significantly better mucosal antibody responses against the foreign antigen.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Immunology,Microbiology,Parasitology

Link

https://journals.asm.org/doi/pdf/10.1128/iai.59.10.3841-3845.1991

Reference38 articles.

1. Clemens J. D. D. A. Sack J. R. Harris J. Chakraborty M. R. Khan B. F. Staanton B. A. Kay M. U. Khan M. Yanus W. Atkinson A. Svennerholm and J. Holmgren. 1986. Field trial of oral cholera vaccines in Bangladesh. Lancet ii:124-127.

2. Use of attenuated mutants of Salmonella as carriers for delivery of heterologous antigens to the secretory immune system;Clements J. D.;Pathol. Immunopathol. Res.,1987

3. Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas;Clements J. D.;Infect. Immun.,1984

4. Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin;Clements J. D.;Infect. Immun.,1986

5. Curtiss R. III R. Goldschmidt S. Kelly M. Lyons S. Michalek R. Pastian and S. Stein. 1987. Recombinant avirulent Salmonella for oral immunization to induce mucosal immunity to bacterial pathogens p. 261-271. In H. Kohler and P. T. LoVerde (ed.) Vaccines: new concepts and developments. Proceedings of the 10th International Convocation on Immunology. Longman Scientific and Technical Harlow Essex United Kingdom.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bactofection, Bacterial-Mediated Vaccination, and Cancer Therapy: Current Applications and Future Perspectives;Vaccines;2024-08-27

2. Live-attenuated auxotrophic mutant of Salmonella Typhimurium expressing immunogenic HA1 protein enhances immunity and protective efficacy against H1N1 influenza virus infection;Future Microbiology;2017-07

3. Preexisting Salmonella -specific immunity interferes with the subsequent development of immune responses against the Salmonella strains delivering H9N2 hemagglutinin;Veterinary Microbiology;2017-06

4. An oral vaccine for type 1 diabetes based on live attenuated Salmonella;Vaccine;2014-04

5. Pre-existing immunity against vaccine vectors – friend or foe?;Microbiology;2013-01-01